"Notice: this publication appears on the PPSG website with the express permission of the copyright holder, who should be consulted for further permission to reproduce."
[Contents]
|
|
|
"Notice: this publication appears on the PPSG website with the express permission of the copyright holder, who should be consulted for further permission to reproduce." |
||
|
||
References
1. World Health Organization Programme on Cancer Control. Developing a global strategy for cancer. Editor: Karol Sikora, March 1998.
2. International Narcotics Control Board. Report of the International Narcotics Control Board for 1998. New York, NY: UN, 1999.
3. International Narcotics Control Board. Availability of opiates for medical needs. In: Report of the International Narcotics Control Board for 1995. New York, NY: UN, 1996.
4. World Health Organization. Cancer pain relief and palliative care: Report of a WHO expert committee (Technical Report Series 804). Geneva, Switzerland: WHO, 1990.
5. World Health Organization. Cancer pain relief with a guide to opioid availability (Second edition). Geneva, Switzerland: WHO, 1996.
6. World Health Organization. Cancer pain relief. Geneva, Switzerland: WHO, 1986.
7. World Health Organization. The use of essential drugs: Report of a WHO Expert Committee (Technical Report Series 882). Geneva, Switzerland: WHO, 1998.
8. World Health Organization. WHO Expert Committee on Drug Dependence. Twenty-eighth report. (Technical Report Series 836). Geneva, Switzerland: WHO, 1993.
9. International Narcotics Control Board. Demand for and supply of opiates for medical and scientific needs. In: Report of the International Narcotics Control Board for 1989. New York, NY: UN, 1989.
10. Joranson DE. Availability of opioids for cancer pain: Recent trends, assessment of system barriers, new World Health Organization guidelines, and the risk of diversion. Journal of Pain and Symptom Management, 8(6):353-360, 1993.
11. Joranson DE. New international efforts to ensure availability of opioids for medical purposes. Journal of Pain and Symptom Management, 12(2):85-86, 1996.
12. United Nations International Drug Control Programme. Format and guidelines for the preparation of national drug control master plans. Vienna, Austria: UN, 1994.
13. Patton CV, Sawicki DS. Basic methods of policy analysis and planning (Second edition). Englewood Cliffs, NJ: Prentice Hall, 1993.
14. Weimer DL, Vining AR. Policy analysis: Concepts and practice (Second edition). Englewood Cliffs, NJ: Prentice Hall, 1992.
15. United Nations International Drug Control Programme. National laws and regulations relating to the control of narcotic drugs and psychotropic substances: Cumulative index 1994. Vienna, Austria: UN, 1994.
16. United Nations. Single Convention on Narcotic Drugs, 1961, as amended by the 1972 Protocol Amending the Single Convention on Narcotic Drugs, 1961. New York, NY: UN, 1977.
17. World Medical Association. World Medical Association declaration on physician independence and professional freedom. Adopted by the 38th World Medical Assembly. Rancho Mirage, CA, USA, October 1986.
18. World Health Organization. National cancer control programmes: Policies and managerial guidelines. Geneva, Switzerland: WHO, 1995.
19. World Health Organization. WHO Expert Committee on Drug Dependence. Sixteenth report. (Technical Report Series 407). Geneva, Switzerland: WHO, 1969.
20. World Health Organization. WHO Expert Committee on Addiction-Producing Drugs. Thirteenth report. (Technical report Series 273). Geneva, Switzerland: WHO, 1964.
21. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders. Clinical descriptions and diagnostic guidelines. Geneva, Switzerland: WHO, 1992.
22. WHO Collaborating Centre for International Drug Monitoring. Print-out from the Adverse Drug Reaction database. Uppsala, Sweden: 1999.